MedPath

Advagen Pharma Ltd.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

53

FDA:53

Drug Approvals

LABETALOL HYDROCHLORIDE

Approval Date
May 21, 2025
FDA

buprenorphine hydrochloride

Approval Date
Mar 13, 2024
FDA

mycophenolic acid

Approval Date
Mar 7, 2024
FDA

Tramadol Hydrochloride

Approval Date
Feb 27, 2024
FDA

Aripiprazole

Approval Date
Dec 27, 2023
FDA

Acyclovir

Approval Date
Dec 27, 2023
FDA

OXCARBAZEPINE

Approval Date
Dec 27, 2023
FDA

Gabapentin

Approval Date
Dec 24, 2023
FDA

POTASSIUM CHLORIDE

Approval Date
Dec 24, 2023
FDA

DESVENLAFAXINE

Approval Date
Dec 19, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.